Reuters logo
BRIEF-OBI Pharma buys TH-3424 from Threshold Pharmaceuticals
June 1, 2017 / 9:09 AM / 6 months ago

BRIEF-OBI Pharma buys TH-3424 from Threshold Pharmaceuticals

June 1 (Reuters) - OBI Pharma Inc

* OBI Pharma announces acquisition of TH-3424 from Threshold Pharmaceuticals

* OBI Pharma says product will be renamed OBI-3424 effective immediately

* OBI Pharma - Threshold to transfer to co its ownership rights as well as preclinical,manufacturing data for OBI-3424 for undisclosed, upfront one-time payment

* OBI Pharma - plans to accelerate development of OBI-3424, with IND application filing with U.S. FDA planned for early 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below